Common Stock, Shares, Outstanding of Kymera Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kymera Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 81,323,532, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kymera Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 81,323,532 +16,433,339 +25% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 71,741,174 +6,992,948 +11% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 70,557,442 +8,985,059 +15% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 65,112,714 +3,759,568 +6.1% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 64,890,193 +9,304,888 +17% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 64,748,226 +9,297,987 +17% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 61,572,383 +6,182,124 +11% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 61,353,146 +6,076,920 +11% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 55,585,305 +545,925 +0.99% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 55,450,239 +698,810 +1.3% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 55,390,259 +3,543,210 +6.8% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 55,276,226 +3,583,560 +6.9% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 55,039,380 +3,503,199 +6.8% 31 Dec 2022 10-Q 02 Nov 2023 2023 Q3
Q3 2022 54,751,429 +3,494,876 +6.8% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 51,847,049 +6,519,368 +14% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 51,692,666 +6,813,290 +15% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 51,536,181 +7,053,995 +16% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 51,256,553 +6,808,819 +15% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 45,327,681 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 44,879,376 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 44,482,186 +42,552,670 +2205% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 44,447,734 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q4 2019 1,929,516 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.